Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Disease Control Technologies (DCT) is a specialized manufacturer of long-lasting insecticidal nets (LLINs) designed to prevent the transmission of malaria and other vector-borne diseases. The company's primary product, DuraNet, is a WHO-prequalified mosquito net that utilizes advanced polyethylene extrusion technology to incorporate insecticide throughout the fibers for long-term efficacy. DCT serves major international health organizations, including the Global Fund, USAID, and UNICEF, providing essential tools for large-scale disease control initiatives. The company is headquartered in South Carolina and maintains significant manufacturing operations to meet global demand for malaria prevention products. By focusing on high-quality, cost-effective solutions, DCT plays a pivotal role in the global effort to eliminate malaria.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Disease Control Technologies.